CELLEX BIOSCIENCES INC
10KSB, EX-27, 2001-01-16
LABORATORY ANALYTICAL INSTRUMENTS
Previous: CELLEX BIOSCIENCES INC, 10KSB, 2001-01-16
Next: AMERICAN HEALTHWAYS INC, 10-Q, 2001-01-16



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         548,000
<SECURITIES>                                         0
<RECEIVABLES>                                1,858,000
<ALLOWANCES>                                   189,000
<INVENTORY>                                  2,302,000
<CURRENT-ASSETS>                             5,561,000
<PP&E>                                         825,000
<DEPRECIATION>                                  57,000
<TOTAL-ASSETS>                               9,881,000
<CURRENT-LIABILITIES>                        1,626,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    10,053,000
<OTHER-SE>                                 (2,279,000)
<TOTAL-LIABILITY-AND-EQUITY>                 9,881,000
<SALES>                                      5,863,000
<TOTAL-REVENUES>                             5,863,000
<CGS>                                        3,970,000
<TOTAL-COSTS>                                3,970,000
<OTHER-EXPENSES>                             3,662,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             152,000
<INCOME-PRETAX>                            (1,884,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,884,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,884,000)
<EPS-BASIC>                                     (0.38)
<EPS-DILUTED>                                   (0.38)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission